AFMD
NSDAffimed N.V.
Healthcare•Biotechnology
Watchlists:
Last updated: Tuesday 20th May 2025
0.18
-0.10 (-34.95%)
Prev Close:0.279
Open:0.2175
Bid:0.1936
Ask:0.2009
52 Week Range
0.078.95
Volume:15,298,098
Mkt Cap:2 M
35
MarketXLS Rank ®
Weak Hold
Price Target
$0.21
+15.7%
Financials
Financial Statements
AFMD - Balance Sheet (Annual)
| Dec-23 | Dec-22 | Invalid date | |
|---|---|---|---|
| Accounts Payable | 19 M | 19 M | |
| Accounts Receivable | 5 M | 3 M | |
| Accrued Expenses | 19 M | 19 M | |
| Accumulated Depreciation & Depletion | -3 M | ||
| Building & Improvements | 8 M | ||
| Cash And Equivalents | 39 M | 190 M | |
| Cash Cash Equivalents And Short Term Investments | 72 M | 190 M | |
| Common Par | 2 M | ||
| Common Stock Equity | 58 M | 153 M | |
| Common Stock | 2 M | ||
| Current Capital Lease Obligation | 539000.0 | 396000.0 | |
| Deferred Revenues | 619000.0 | 9 M | |
| Float Term Debt | 6 M | 12 M | |
| Goodwill And Other Intangible Assets | 25000.0 | 58000.0 | |
| Gross Fixed Assets (plant Property & Equipment) | 16 M | 4 M | |
| Intangibles | 25000.0 | 58000.0 | |
| Inventories | 463000.0 | 628000.0 | |
| Invested Capital | 64 M | 164 M | |
| Leases | 52000.0 | ||
| Long Term Capital Lease Obligation | 7 M | 176000.0 | |
| Long Term Debt And Capital Lease Obligation | 13 M | 12 M | |
| Machinery Furniture & Equipment | 8 M | ||
| Net Fixed Assets (net PP&E) | 13 M | 4 M | |
| Non Current Deferred Liabilities | 464000.0 | 1 M | |
| Other Current Assets | 6 M | 2 M | |
| Other Equity Adjustments | 592 M | 583 M | |
| Other Non-current Liabilities | -1 M | ||
| Other Current Borrowings | 6 M | 6 M | |
| Other Current Liabilities | 1 M | ||
| Other Inventories | 463000.0 | ||
| Other Payable | 2 M | ||
| Payables | 19 M | 19 M | |
| Retained Earnings | -536 M | -430 M | |
| Short Term Debt | 6 M | 6 M | |
| Taxes Receivable | 2 M | ||
| Total Assets | 97 M | 201 M | |
| Total Current Assets | 84 M | 196 M | |
| Total Current Liabilities | 26 M | 35 M | |
| Total Equity | 58 M | 153 M | |
| Total Liabilities | 39 M | 48 M | |
| Total Non-current Assets | 13 M | 4 M | |
| Total Non-current Liabilities | 13 M | 13 M | |
| Total Equity Gross Minority | 58 M | 153 M | |
| Total Equity Gross Minority Interest | 58 M | 153 M | |
| Total Liabilities And Total Equity Gross Minority Interest | 97 M | 201 M | |
| Total Non Current Liabilities Net Minority Interes | 13 M | 13 M | |
| Unrealized Gain Loss | 592 M | 583 M | |
| Working Capital | 58 M | 161 M | |
| Debtc | 6 M | 6 M |
Call: 1-877-778-8358 
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.
I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement "your own" investment strategies in Excel with thousands of MarketXLS functions and templates.
MarketXLS provides all the tools I need for in-depth stock analysis. It's user-friendly and constantly improving. A must-have for serious investors.
I have been using MarketXLS for the last 6+ years and they really enhanced the product every year and now in the journey of bringing in AI...
MarketXLS is a powerful tool for financial modeling. It integrates seamlessly with Excel and provides real-time data.
I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel.